- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
RPG Life Sciences Limited — Updates, 17-10-2025: Press Release
17-10-2025 | 06:15 pm
17-10-2025 | 06:15 pm
RPG Life Sciences' Q2 FY26 revenue rose 7.6% Q-o-Q to Rs. 181.7 Cr, with EBITDA margins strong at 24%. H1 FY26 revenue grew 3.8%. Domestic formulations significantly outperformed the Indian Pharma Market.
No comments yet. Be the first to comment!